Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19.

Mohamed H AbdelazimFaisal AlsenaniMohammed AlnuhaitAbdullah S AlshammariAbdullah H AltemaniEyad A AlthagafiDania S WaggasAhmed H AbdelazimAdnan Alharbi

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2024)

DFM-IRB00012367-23-10-001.

Keyphrases

coronavirus disease
sars cov
oxidative stress
respiratory syndrome coronavirus
drug induced